Lilly files six lawsuits over illegal sales of unapproved obesity drug retatrutide
Eli Lilly (LLY) has filed six lawsuits against US companies it accuses of illegally selling unauthorized versions of its experimental obesity drug retatrutide, escalating its crackdown on black-market sellers before the medicine has…
